Table 2 ADAMTS-1 expression (median value) according to clinicopathological features and biomolecular markers in primary breast tumors
From: Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion
Variable | Categories | n | ADAMTS-1 expression | p value |
|---|---|---|---|---|
Age (years old) | < 50 | 22 | 0.350 | MW: 0.534 |
≥ 50 | 38 | 0.475 | ||
Stage (TNM) | Stage I | 2 | 0.225 | KW: 0.006 |
Stage II | 25 | 0.250 | ||
Stage III | 26 | 0.625 | ||
Stage IV | 7 | 1.100 | ||
Tumor size (cm) | < 4.0 | 21 | 0.350 | MW:0.950 |
≥ 4.0 | 39 | 0.400 | ||
Lymph node metastasis | No | 20 | 0.450 | MW: 0.712 |
Yes | 40 | 0.350 | ||
Estrogen receptor | Negative | 27 | 0.350 | MW: 0.291 |
Positive | 33 | 0.600 | ||
Progesterone receptor | Negative | 33 | 0.550 | MW: 0.731 |
Positive | 26 | 0.350 |